Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 4, 2008, Pages 678-684

  Bonderman, Diana ^a   Jakowitsch, Johannes ^a   Redwan, Bassam ^a   Bergmeister, Helga ^a   Renner, Maria Klara ^a   Panzenböck, Heidi ^a   Adlbrecht, Christopher ^a   Georgopoulos, Apostolos ^a   Klepetko, Walter ^a   Kneussl, Meinhard ^b   Lang, Irene M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Medical Department   (Austria)

Author keywords

Infection; Pulmonary embolism; Thrombus resolution

Indexed keywords

BACTERIAL DNA; BACTERIAL RNA; CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; COLLAGEN; IMMEDIATE EARLY PROTEIN; PRIMER DNA; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDARTERECTOMY; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; HUMAN; HUMAN TISSUE; LUNG BLOOD VESSEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; THROMBOEMBOLISM; THROMBUS; THROMBUS INFECTION; TISSUE REPAIR; UPREGULATION; VASCULAR FIBROSIS; VEIN BLOOD FLOW; VEIN THROMBOSIS; VENTRICULOATRIAL SHUNT; ADOLESCENT; ADULT; AGED; ANIMAL; ARTIFICIAL HEART PACEMAKER; BAGG ALBINO MOUSE; CEREBROSPINAL FLUID SHUNTING; FEMALE; GENETICS; HEART ATRIUM; HYDROCEPHALUS; INFERIOR CAVA VEIN; ISOLATION AND PURIFICATION; LUNG EMBOLISM; METABOLISM; MICROBIOLOGY; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PATHOLOGY; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BASE SEQUENCE; CEREBROSPINAL FLUID SHUNTS; COLLAGEN; DNA PRIMERS; DNA, BACTERIAL; FEMALE; HEART ATRIA; HUMANS; HYDROCEPHALUS; HYPERTENSION, PULMONARY; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PULMONARY EMBOLISM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 42249087000     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.156000     Document Type: Article

References (46)

1. Menendez R, Nauffal D, Cremades MJ. Prognostic factors in restoration of pulmonary flow after submassive pulmonary embolism: a multiple regression analysis. Eur Respir J. 1998;11:560-564.
2. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001;345:1465-1472.
3. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, Albanese P, Biasiolo A, Pegoraro C, Iliceto S, Prandoni P. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257-2264.
4. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990;81:1735-1743.
5. Lang IM. Chronic thromboembolic pulmonary hypertension-not so rare after all. N Engl J Med. 2004;350:2236-2238.
6. Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, Simonneau G. Thrombotic risk factors in pulmonary hypertension. Eur Respir J. 2000;15:395-399.
7. Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation. 1992;86:1241-1248.
8. Lang IM, Marsh JJ, Olman MA, Moser KM, Schleef RR. Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli. Circulation. 1994;90:706-712.
9. Marsh JJ, Konopka RG, Lang IM, Wang HY, Pedersen C, Chiles P, Reilly CF, Moser KM. Suppression of thrombolysis in a canine model of pulmonary embolism. Circulation. 1994;90:3091-3097.
10. Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J. 2000;15:440-448.
11. Lang IM, Marsh JJ, Olman MA, Moser KM, Loskutoff DJ, Schleef RR. Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli. Circulation. 1994;89:2715-2721.
12. Bonderman D, Jakowitsch J, Adlbrecht C, Schemper M, Kyrle PA, Schonauer V, Exner M, Klepetko W, Kneussl MP, Maurer G, Lang I. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2005;93:512-516.
13. Bonderman D, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Dunkler D, Taghavi S, Klepetko W, Kneussl M, Lang IM. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007;115:2153-2158.
14. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis. 1975;131:543-552.
15. Colli BO, Starr EM, Martelli N. [Surgical treatment of hydrocephalus in children. II. Complications]. Ar Qneuropsiquiatr. 1981;39:408-419.
16. Rockey DC. Hepatic fibrogenesis and hepatitis C. Semin Gastrointest Dis. 2000;11:69-83.
17. Vassallo R. Viral-induced inflammation in interstitial lung diseases. Semin Respir Infect. 2003;18:55-60.
18. Li Z, Li J. Local expressions of TGF-β1, TGF-β1RI, CTGF, and Smad-7 in Helicobacter pylori-associated gastritis. Scand J Gastroenterol. 2006;41:1007-1012.
19. Meneghin A, Hogaboam CM. Infectious disease, the innate immune response, and fibrosis. J Clin Invest. 2007;117:530-538.
20. Bannerman DD, Paape MJ, Chockalingam A. Staphylococcus aureus intramammary infection elicits increased production of transforming growth factor-α, β1, and β2. Vet Immunol Immunopathol. 2006;112:309-315.
21. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. Faseb J. 1999;13:1774-1786.
22. Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. FASEB J. 2004;18:816-827.
23. Jamieson SW. Pulmonary thromboendarterectomy. Heart. 1998;79:118-120.
24. Verrel F, Ruppert V, Spengel FA, Steckmeier B. Stage-adapted therapy concept in ascending thrombophlebitis. Zentralbl Chir. 2001;126:531-536.
25. Singh I, Burnand KG, Collins M, Luttun A, Collen D, Boelhouwer B, Smith A. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation. 2003;107:869-875.
26. Lopez-De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem. 1985;33:737-743.
27. Garvey W, Fathi A, Bigelow F, Carpenter B, Jimenez C. A combined elastic, fibrin and collagen stain. Stain Technol. 1987;62:365-368.
28. Singh I, Smith A, Vanzieleghem B, Collen D, Burnand K, Saint-Remy JM, Jacquemin M. Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model. Blood. 2002;99:3235-3240.
29. Lang IM, Moser KM, Schleef RR. Elevated expression of urokinase-like plasminogen activator and plasminogen activator inhibitor type 1 during the vascular remodeling associated with pulmonary thromboembolism. Arterioscler Thromb Vasc Biol. 1998;18:808-815.
30. Modarai B, Burnand KG, Sawyer B, Smith A. Endothelial progenitor cells are recruited into resolving venous thrombi. Circulation. 2005;111:2645-2653.
31. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44:62-69.
32. Broberg CS, Ujita M, Prasad S, Li W, Rubens M, Bax BE, Davidson SJ, Bouzas B, Gibbs JS, Burman J, Gatzoulis MA. Pulmonary arterial thrombosis in eisenmenger syndrome is associated with biventricular dysfunction and decreased pulmonary flow velocity. J Am Coll Cardiol. 2007;50:634-642.
33. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension Circulation. 2006;113:2011-2020.
34. Petersen JW, Felker GM. Inflammatory biomarkers in heart failure. Congest Heart Fail. 2006;12:324-328.
35. Brogden KA, Roth JA, Stanton TB, Bolin CA, Minion FC, Wannemuehler MJ. Virulence Mechanisms of Bacterial Pathogens. Washington, DC: ASM Press; 2000.
36. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007;117:524-529.
37. Khalil N, Xu YD, O'Connor R, Duronio V. Proliferation of pulmonary interstitial fibroblasts is mediated by transforming growth factor-β1- induced release of extracellular fibroblast growth factor-2 and phosphorylation of p38 MAPK and JNK. J Biol Chem. 2005;280:43000-43009.
38. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ. 1996;7:469-480.
39. Kempf VA, Lebiedziejewski M, Alitalo K, Walzlein JH, Ehehalt U, Fiebig J, Huber S, Schutt B, Sander CA, Muller S, Grassl G, Yazdi AS, Brehm B, Autenrieth IB. Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor-1 in bacterial infections. Circulation. 2005;111:1054-1062.
40. Hong KH, Yoo SA, Kang SS, Choi JJ, Kim WU, Cho CS. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts. Clin Exp Immunol. 2006;146:362-370.
41. Aasen AO, Wang JE. Mediator responses in surgical infections. Surg Infect (Larchmt). 2006;7 Suppl 2:S3-S4.
42. Gomez MI, O'Seaghdha M, Magargee M, Foster TJ, Prince AS. Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem. 2006;281:20190-20196.
43. Guo G, Morrissey J, McCracken R, Tolley T, Klahr S. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol. 1999;277:F766-F772.
44. Henke PK, Varma MR, Deatrick KB, Dewyer NA, Lynch EM, Moore AJ, Dubay DA, Sukheepod P, Pearce CG, Upchurch GR Jr, Kunkel SL, Franz MG, Wakefield TW. Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost. 2006;95:272-281.
45. Ali T, Humphries J, Burnand K, Sawyer B, Bursill C, Channon K, Greaves D, Rollins B, Charo IF, Smith A. Monocyte recruitment in venous thrombus resolution. J Vasc Surg. 2006;43:601-608.
46. Baran J, Guzik K, Hryniewicz W, Ernst M, Flad HD, Pryjma J. Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria. Infect Immun. 1996;64:4242-4248.